Advertisement
News
Advertisement

EnWave Chairman Wins LifeSciences B.C. Innovation & amp; Achievement Award

Thu, 03/08/2012 - 4:45am
The Associated Press

(http://www.enwave.net/)

EnWave Corporation (TSX VENTURE: ENW)(FRANKFURT: E4U) ("EnWave" or

"the Company") today announced that LifeSciences British Columbia

("LSBC") has awarded Dr. Timothy Durance, Chairman and Co-CEO of

EnWave, with the 2012 Innovation & Achievement Award for his

development of EnWave's Radiant Energy Vacuum ("REV") technology.

This award is presented annually by LSBC to recognize individuals and

organizations that have made outstanding contributions to the

development of British Columbia's life sciences industry across all

sub-sectors, from biopharmaceuticals and medical devices to

bioproducts and bioenergy - sectors which are critical to the economic

future of the province and country.

"This year's award winners are outstanding," stated Don Enns,

President of LifeSciences BC. "British Columbia has some great leaders

in biotech, and the four individuals and one company selected for

these awards are incredible innovators. Our sector is world-class, and

these winners represent significant achievements resulting in economic

growth for B.C."

"Over the past year, we have made significant technological

advancements in relation to the efficient dehydration of

biopharmaceuticals," stated Dr. Durance. "I am sincerely humbled by

this noteworthy recognition. The innovation and achievement that

EnWave has accomplished thus far in the life sciences space is very

encouraging."

The LifeSciences British Columbia Awards will be presented at a gala

ceremony the evening of Thursday, April 19th, 2012, in front of an

audience of approximately 600 guests representing the

biopharmaceutical, medical device, bioproducts, bioenergy and greater

life sciences community at the Vancouver Convention Centre.

About LifeSciences British Columbia

LifeSciences British Columbia is a not-for-profit, non-government

industry association that represents and supports the

biopharmaceutical, medical device, bioproducts, bioenergy and greater

life sciences community of British Columbia through facilitation of

partnering and investment, advocacy, education, and promotion of our

world-class science and industry. More information about LifeSciences

B.C. is available at

http://www.lifesciencesbc.ca/(http://www.lifesciencesbc.ca/).

About EnWave

EnWave Corporation is a Vancouver-based industrial technology company

developing commercial applications for its proprietary Radiant Energy

Vacuum (REV) dehydration technology. In collaboration with an

expanding list of multinational partners, including Nestle, Kellogg's,

Grupo Bimbo, Grimmway Farms, Ocean Spray Cranberries, Hormel,

Bonduelle and Merck. EnWave is introducing REV as a new dehydration

standard in the food and biological material sectors: potentially

faster and cheaper than freeze drying, with better end product quality

than air drying or spray drying.

EnWave currently has six REV platforms: commercial-scale nutraREV and

MIVAP are used in the food industry to dry fruits, vegetables, meat,

herbs and seafood quickly and at low-cost, while maintaining high

levels of nutrition, taste, texture and colour. The Company is also

developing powderREV for bulk dehydration of food cultures,

probiotics and fine biochemicals such as enzymes; quantaREV for

continuous, high-volume low-temperature drying of pastes, gels,

liquids, or particulates; and bioREV and freezeREV as new methods to

stabilize and dehydrate biopharmaceuticals such as vaccines and

antibodies. More information about EnWave is available at

www.enwave.net(http://www.enwave.net).

EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press

release may contain forward-looking information based on management's

expectations, estimates and projections. All statements that address

expectations or projections about the future, including statements

about the Company's strategy for growth, product development, market

position, expected expenditures and financial results are

forward-looking statements. These statements are not a guarantee of

future performance and involve a number of risks, uncertainties and

assumptions. There is no guarantee that the Company's REV technology

can or will improve processes in the target industry; even if the

Company's REV technology can be used as described in this document,

there is no guarantee that such use will result in orders for the

Company's REV technology. All figures comparing REV technologies to

freeze drying or other dehydration technologies are provided as

examples of data obtained through the Company's own scientific and

testing programs; each product must be tested individually to

determine the benefits of using REV.

Neither the TSX Venture Exchange nor its Regulation Services Provider

(as that term is defined in the policies of the TSX Venture Exchange)

accepts responsibility for the adequacy or accuracy of this release.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading